Atrial fibrillation complicating acute myocardial infarction: How should it be interpreted and how should it be treated and prevented?

European Heart Journal

Volumn 30, Issue 9, 2009, Pages 1035-1037

  Cappato, Riccardo ^a  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART INFARCTION; AGING; ANTICOAGULANT THERAPY; CARDIOVERSION; CLINICAL FEATURE; EDITORIAL; HEART ATRIUM FIBRILLATION; HEART ATRIUM INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE INFARCTION; HEMODYNAMICS; HUMAN; HYPOKALEMIA; HYPOXIA; MORBIDITY; MORTALITY; PERICARDITIS; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION;

ATRIAL FIBRILLATION; HUMANS; MYOCARDIAL INFARCTION; PROGNOSIS; RISK ASSESSMENT;

EID: 65949084010     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp154     Document Type: Editorial

References (4)

1. Lordkipanidzé M, Pharand C, Nguyen TA, Schampaert E, Palisaitis DA, Diodati JG. Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients. Eur Heart J 2008;29:2877-2885.
2. Siller-Matula J, Schrö r K, Wojta J, Huber K. Thienopyridines in cardiovascular disease: focus on clopidogrel resistance. Thromb Haemost 2007;97:385-393.
3. Price MJ. Monitoring platelet function to reduce the risk of ischemic and bleeding complications. Am J Cardiol 2009;103(3 Suppl.):35A-39A.
4. KuliczkowskiW, Witkowski A, Polonski L,Watala C, Filipiak K, Budaj A, Golanski J, Sitkiewicz D, Pregowski J, Gorski J, Zembala M, Opolski G, Huber K, Arnesen H, Kristensen SD, De Caterina R. Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J 2009;30:426-435.